Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
First-time investors can benefit greatly from expert advice. Learn key strategies to navigate the investment landscape effectively.
28,248 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Investors are eyeing a potential rebound for Figma as enterprise adoption grows and AI-driven updates sharpen the pla...
A late-appeal by a U.S. president over Balogun’s red card has thrown FIFA's neutrality into the spotlight, with poten...
As market conditions shift in 2026, five very safe high-yield dividend stocks stand out for lifelong ownership, backe...
Ferrari's latest results underscore its asset-like status, delivering strong cash flow while preparing for an electri...
Walmart stock faces a balanced 2026–2030 path, with growth from e-commerce and membership services battling cost pres...
Rithm Capital priced a $500 million offering of senior unsecured notes due 2031, signaling a continued push to streng...
The U.S. market is blazing, but a surprising nation has surged 10x U.S. stock gains since early 2025. Here's what inv...
A smart way to jump into AI semiconductors starts with a modest, well-balanced plan. Here are three no-brainer AI sto...
An in-depth look at how much SCHD would be required to replace Social Security income, with current yields, market co...
Meta is pressing ahead with a sweeping AI infrastructure plan even after laying 8,000 employees. CEO Mark Zuckerberg ...
NVIDIA is expanding beyond its GPU roots to build a broad AI infrastructure platform, funded by a growing investment ...